110 related articles for article (PubMed ID: 7497456)
21. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture.
Swiatecka J; Dziecioł J; Anchim T; Dabrowska M; Pietruczuk M; Wołczyński S
Neoplasma; 2000; 47(1):15-24. PubMed ID: 10870682
[TBL] [Abstract][Full Text] [Related]
22. Growth effects of tamoxifen on Lovo colon carcinoma cells and cultured cells from normal colonic mucosa.
Lointier P; Wildrick DM; Boman BM
Anticancer Res; 1992; 12(5):1523-5. PubMed ID: 1444215
[TBL] [Abstract][Full Text] [Related]
23. Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.
Chen YR; Tsou B; Hu S; Ma H; Liu X; Yen Y; Ann DK
Oncotarget; 2016 Jan; 7(2):1984-99. PubMed ID: 26675256
[TBL] [Abstract][Full Text] [Related]
24. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
Roberts CG; Millar EK; O'Toole SA; McNeil CM; Lehrbach GM; Pinese M; Tobelmann P; McCloy RA; Musgrove EA; Sutherland RL; Butt AJ
Oncogene; 2011 Jul; 30(28):3186-97. PubMed ID: 21383694
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB
Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290
[TBL] [Abstract][Full Text] [Related]
26. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
27. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.
Ercoli A; Scambia G; Fattorossi A; Raspaglio G; Battaglia A; Cicchillitti L; Malorni W; Rainaldi G; Benedetti Panici P; Mancuso S
Int J Cancer; 1998 Mar; 76(1):47-54. PubMed ID: 9533761
[TBL] [Abstract][Full Text] [Related]
28. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
[TBL] [Abstract][Full Text] [Related]
29. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
Planas-Silva MD; Waltz PK; Kilker RL
J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
[TBL] [Abstract][Full Text] [Related]
30. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
Hodges-Gallagher L; Valentine CD; Bader SE; Kushner PJ
Breast Cancer Res Treat; 2007 Nov; 105(3):297-309. PubMed ID: 17186358
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
Shen F; Xue X; Weber G
Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
[TBL] [Abstract][Full Text] [Related]
33. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
34. The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.
Gee JM; Harper ME; Hutcheson IR; Madden TA; Barrow D; Knowlden JM; McClelland RA; Jordan N; Wakeling AE; Nicholson RI
Endocrinology; 2003 Nov; 144(11):5105-17. PubMed ID: 12960029
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.
Wei JW; Hickie RA; Klaassen DJ
Cancer Chemother Pharmacol; 1983; 11(2):86-90. PubMed ID: 6627600
[TBL] [Abstract][Full Text] [Related]
36. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of melanoma cell/matrix interaction by tamoxifen.
Mac Neil S; Wagner M; Kirkham PR; Blankson EA; Lennard MS; Goodall T; Rennie IG
Melanoma Res; 1993 Feb; 3(1):67-74. PubMed ID: 8471839
[TBL] [Abstract][Full Text] [Related]
38. The role of calmodulin in the regulation of osteoclastogenesis.
Zhang L; Feng X; McDonald JM
Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067
[TBL] [Abstract][Full Text] [Related]
39. [Effect of calmodulin antagonist on chemosensitivity of primary cultured lung cancer cells].
Xiong W; Shen H
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):347-9. PubMed ID: 8697972
[TBL] [Abstract][Full Text] [Related]
40. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
Perry RR; Kang Y; Greaves BR
Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
